Healt


 Mesoblast Limited Shares Soar On Completion Of Partnership With China’s Tasly Pharmaceutical

Mesoblast Limited Shares Soar On Completion Of Partnership With China’s Tasly Pharmaceutical

October 12, 2018 05:47 AM AEDT| By Team Kalkine Media

Mesoblast Limited (ASX: MSB) rushed on Australian Securities Exchange after the group completed long standing strategic partnership deal with China?s Tasly Pharmaceutical Group. At the time of writing, the stock price of MSB has jumped as high as 3.2...

 Medical Developments International Limited – Green Signal For Penthrox In Saudi Arabia

Medical Developments International Limited – Green Signal For Penthrox In Saudi Arabia

October 11, 2018 09:10 AM AEDT| By Team Kalkine Media

After Medical Developments International Limited?s (ASX: MVP) exclusive deal for Penthrox in China , MVP has been ?granted marketing authorization for the Penthrox medicine in Kingdom of Saudi Arabia (KSA). This authorization is granted by Saudi Food...

 Clinuvel Pharmaceuticals Ltd advised on Appeal Against NICE Recommendation in England

Clinuvel Pharmaceuticals Ltd advised on Appeal Against NICE Recommendation in England

October 10, 2018 09:55 AM AEDT| By Team Kalkine Media

Clinuvel Pharmaceuticals Ltd (ASX: CUV) and other three consultee organisations representing the erythropoietic protoporphyria? patients (EPP patients) and expert physician requested the appeal hearing appointed by NICE (National Institute of Health...

 Cochlear Announces Next Phase In Development Of Totally Implantable Cochlear Implant Technology

Cochlear Announces Next Phase In Development Of Totally Implantable Cochlear Implant Technology

October 10, 2018 05:57 AM AEDT| By Team Kalkine Media

Cochlear (ASX: COH) recently announced the next phase in long-term research and development program with the start of a further clinical feasibility study. A further clinical feasibility study has been initiated to evaluate the totally implantable co...

 Medibio (ASX: MEB) Introduces Corporate Health Product Named “Ilumen”

Medibio (ASX: MEB) Introduces Corporate Health Product Named “Ilumen”

October 09, 2018 07:44 AM AEDT| By Team Kalkine Media

Medibio Limited (ASX: MEB) from healthcare industry announces to introduce its new product ?ilumen? for corporate customers which has a capability to offer biometric analysis and objective, provide data-driven feedback as well assess mental wellness...

 What’s Happening To Cochlear’s Share Price?

What’s Happening To Cochlear’s Share Price?

October 09, 2018 06:44 AM AEDT| By Team Kalkine Media

Cochlear Limited (ASX: COH) has been witnessing a strong downtrend since morning. At the time of writing, the stock price stands at A$191.040 per share which implies an intra-day fall of $11.340 or 5.603%. The stock price tumbled as a result of the F...

 Medical Developments International Entered Penthrox Agreement With China And Daiichi Sankyo

Medical Developments International Entered Penthrox Agreement With China And Daiichi Sankyo

October 08, 2018 10:03 AM AEDT| By Team Kalkine Media

Medical Developments International Limited (ASX: MVP) is happy to announce its agreement on Penthrox (a non-opioid analgesic used for pain relief for patients suffering from trauma or those requiring analgesics during surgeries) with Daiichi Sankyo l...

 Medibio Announces Regarding Notice Received Under Section 249D Of The Corporations Act

Medibio Announces Regarding Notice Received Under Section 249D Of The Corporations Act

October 05, 2018 08:58 AM AEST| By Team Kalkine Media

On 1 October 2018, the Medibio Limited (ASX: MEB) announced that on 28 September it received a notice under Section 249D of the Corporations Act 2001 (Section 249D Notice) requesting the Company call and arrange to hold a meeting of the members of th...

 Capitol Health Provided Update Regarding Additional MRI Medicare License Process

Capitol Health Provided Update Regarding Additional MRI Medicare License Process

October 05, 2018 06:04 AM AEST| By Team Kalkine Media

Capitol Health Ltd (ASX: CAJ) is mainly involved in the operations of providing imaging services in Australian Healthcare market. On 5 October 2018, the company provided an update regarding the Federal Government?s recent announcement about the pendi...

 AirXpanders, Inc. (ASX: AXP) flags high satisfaction and treatment success of its latest version of AeroForm device 

AirXpanders, Inc. (ASX: AXP) flags high satisfaction and treatment success of its latest version of AeroForm device 

October 04, 2018 09:00 AM AEST| By Team Kalkine Media

After dipping 4.54% yesterday, the shares of Airxpanders (ASX: AXP) traded in massive volumes on the news of treatment success demonstrated in the study conducted on the latest version of AeroForm. Today, on 4 October 2018, medical device company Air...

 Bionomics Ltd (ASX: BNO) Moves In Red Today!

Bionomics Ltd (ASX: BNO) Moves In Red Today!

October 02, 2018 06:12 AM AEST| By Team Kalkine Media

Bionomics Limited (ASX:BNO), the clinical stage biopharmaceutical company, has fallen in the red zone with a significant fall of about 56% on October 02, 2018 (1:00 PM AEST), after announcing a discouraging clinical trial result for its BNC210 drug....

 Nufarm's Brokers Search Buyers For $75m Shortfall

Nufarm's Brokers Search Buyers For $75m Shortfall

September 28, 2018 04:24 AM AEST| By Team Kalkine Media

Nufarm Limited (ASX: NUF) is in the business of developing and selling of crop protection products in Asia, Australia, Latin America, Europe and New Zealand. According to the recent news, the company?s brokers, Macquarie Capital and UBS are trying to...

 One Of The Biggest Losers On ASX - Australian Pharmaceuticals Industries

One Of The Biggest Losers On ASX - Australian Pharmaceuticals Industries

September 26, 2018 09:06 AM AEST| By Team Kalkine Media

On September 26, 2018, Australian Pharmaceuticals Industries (ASX: API) was among the top losers on Australian Securities Exchange. The company didn?t come up with any news in the morning. However, Credit Suisse downgraded the stock which could be th...

 Nufarm Limited (ASX: NUF) - Australia’s dry weather hit to $15.6 million loss in FY18

Nufarm Limited (ASX: NUF) - Australia’s dry weather hit to $15.6 million loss in FY18

September 26, 2018 05:28 AM AEST| By Team Kalkine Media

Nufarm Limited collapsed to $15.6 million loss for fiscal year 2018 compared to $114.5 million profit after tax last year.? Early this morning the company announced its long awaited full year results to 31 July 2018 along with a fully underwritten pr...

 MGC’s securities suspended from quotation; company seeks $0.5 million plus damages from Varm Cosmo

MGC’s securities suspended from quotation; company seeks $0.5 million plus damages from Varm Cosmo

September 25, 2018 05:02 AM AEST| By Team Kalkine Media

The securities of MGC Pharmaceuticals stopped trading on ASX today as the company has requested for voluntary suspension from the Australian Securities Exchange on 25 September 2018. Since then the share price of MXC has shown no daily price movement...

 3 Biotech/ Pharma Plays of Interest – BNO, NAN, TLX

3 Biotech/ Pharma Plays of Interest – BNO, NAN, TLX

September 24, 2018 05:05 AM AEST| By Team Kalkine Media

BIONOMICS LIMITED (ASX: BNO) About Bionomics and glimpse of financial position Bionomics Limited (ASX: BNO) primarily has operations into two segments named: drug discovery & development as well as contract services. The company is having drug...

 Cynata Therapeutics Limited Releases Its Preclinical Study Outcome

Cynata Therapeutics Limited Releases Its Preclinical Study Outcome

September 21, 2018 08:59 AM AEST| By Team Kalkine Media

Cynata Therapeutics Limited?s (ASX: CYP) stock edged up 0.413 percent on 21 September 2018 at the back of positive market sentiment related to affirmative preclinical study of preclinical model which demonstrates its proprietary Cymerus? mesenchymal...

 Rhinomed Limited (ASX: RNO) - Nasal cannabis deal with US developer Columbia Care expected for completion in September

Rhinomed Limited (ASX: RNO) - Nasal cannabis deal with US developer Columbia Care expected for completion in September

September 20, 2018 09:38 AM AEST| By Team Kalkine Media

Medical technology company Rhinomed Limited is underway the completion of licensing deal with US-based leading medical marijuana operator, Columbia Care LLC. With this agreement both the medical sector companies aim to jointly develop patented cannab...

 Capitol Health Limited’s Share Price remained Flat after acquiring 9 Clinics

Capitol Health Limited’s Share Price remained Flat after acquiring 9 Clinics

September 18, 2018 05:13 AM AEST| By Team Kalkine Media

Capitol Health Limited (ASX: CAJ) is a provider of diagnostic imaging services like x-ray, ultrasound, Doppler, CT scan, Cone beam CT, computer tomography etc. The company provides its services to healthcare markets in Australia. Currently, the compa...

 Strategic alliance with China’s Tasly receives green signa

Strategic alliance with China’s Tasly receives green signa

September 17, 2018 09:20 AM AEST| By Team Kalkine Media

After receiving Chinese government?s approval to overseas direct investment last month, China-based Tasly Pharmaceutical Group has secured all regulatory approvals to close the investment agreement and the development and collaboration agreement with...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.